Crohn's & Colitis Foundation
@crohnscolitisfdn.bsky.social
This Crohn’s & Colitis Awareness Week, we’re showing what #IBDLooksLike and encouraging open conversations about IBD. Ambassadors Kimberly Hooks, Liam Robertson, and Dr. Megan Riehl share tips on discussing Crohn’s and colitis. Read more: https://bit.ly/4889YHw #CrohnsAndColitisAwarenessWeek
November 25, 2025 at 6:18 PM
This Crohn’s & Colitis Awareness Week, we’re showing what #IBDLooksLike and encouraging open conversations about IBD. Ambassadors Kimberly Hooks, Liam Robertson, and Dr. Megan Riehl share tips on discussing Crohn’s and colitis. Read more: https://bit.ly/4889YHw #CrohnsAndColitisAwarenessWeek
Meet Kara, winner of our Crohn’s & Colitis Awareness Week T-shirt contest! Diagnosed with Crohn's disease at just 11, Kara’s strength inspires many. Watch her proudly show off her winning design. Donate $50 by 12/7 to get your own and support people like Kara living with IBD! https://bit.ly/4na61Zi
November 24, 2025 at 5:54 PM
Meet Kara, winner of our Crohn’s & Colitis Awareness Week T-shirt contest! Diagnosed with Crohn's disease at just 11, Kara’s strength inspires many. Watch her proudly show off her winning design. Donate $50 by 12/7 to get your own and support people like Kara living with IBD! https://bit.ly/4na61Zi
IBD doesn’t look like just one thing — it looks like millions of moments, people, and reasons to push for cures. 💜 Hear why Foundation Social Media Ambassador Victoria Tyler calls the Real Life with IBD Guide a must-have. Download the guide today: https://bit.ly/3g2iLiV
November 22, 2025 at 9:05 PM
IBD doesn’t look like just one thing — it looks like millions of moments, people, and reasons to push for cures. 💜 Hear why Foundation Social Media Ambassador Victoria Tyler calls the Real Life with IBD Guide a must-have. Download the guide today: https://bit.ly/3g2iLiV
Chinese scientists tested a magnetic bacteria pill to detect ulcerative colitis and other GI diseases in mice. Dr. Alan Moss, the Foundation's Chief Scientific Officer, told UPI this approach could one day complement colonoscopies but needs human studies first. https://bit.ly/43FMhFi
November 21, 2025 at 4:15 PM
Chinese scientists tested a magnetic bacteria pill to detect ulcerative colitis and other GI diseases in mice. Dr. Alan Moss, the Foundation's Chief Scientific Officer, told UPI this approach could one day complement colonoscopies but needs human studies first. https://bit.ly/43FMhFi
A study in Inflammatory Bowel Diseases® found that upadacitinib (an oral version of Rinvoq) helped nearly 50% of people with moderate-to-severe Crohn’s achieve lasting remission and reduce or stop steroid use, helping them manage symptoms and avoid serious side effects. ➡️ https://bit.ly/4oy5KQO
November 19, 2025 at 4:22 PM
A study in Inflammatory Bowel Diseases® found that upadacitinib (an oral version of Rinvoq) helped nearly 50% of people with moderate-to-severe Crohn’s achieve lasting remission and reduce or stop steroid use, helping them manage symptoms and avoid serious side effects. ➡️ https://bit.ly/4oy5KQO
Crohn’s & Colitis Awareness Week is just around the corner— a time to shine a light on the real experiences behind Crohn’s disease and ulcerative colitis.
Visit our page to explore resources, download the free Real Life with IBD Guide, make a donation, and share your story: https://bit.ly/3g2iLiV
Visit our page to explore resources, download the free Real Life with IBD Guide, make a donation, and share your story: https://bit.ly/3g2iLiV
November 18, 2025 at 3:17 PM
Crohn’s & Colitis Awareness Week is just around the corner— a time to shine a light on the real experiences behind Crohn’s disease and ulcerative colitis.
Visit our page to explore resources, download the free Real Life with IBD Guide, make a donation, and share your story: https://bit.ly/3g2iLiV
Visit our page to explore resources, download the free Real Life with IBD Guide, make a donation, and share your story: https://bit.ly/3g2iLiV
Our new Strategic Plan Progress Tracker is up! We’re committed to transparency with the IBD community. Now it’s even easier to see how we are moving the needle in achieving our strategic plan goals. Read more and track our progress: https://bit.ly/440bMRN
November 12, 2025 at 5:12 PM
Our new Strategic Plan Progress Tracker is up! We’re committed to transparency with the IBD community. Now it’s even easier to see how we are moving the needle in achieving our strategic plan goals. Read more and track our progress: https://bit.ly/440bMRN
Make your voice heard—urge your Representative to support the Safe Step Act! This vital bill would stop harmful insurance delays and help people with IBD get the treatments their doctors prescribe as soon as they need them. Take 30 seconds today to make your voice heard: https://bit.ly/3JS0lVn
November 11, 2025 at 9:00 PM
Make your voice heard—urge your Representative to support the Safe Step Act! This vital bill would stop harmful insurance delays and help people with IBD get the treatments their doctors prescribe as soon as they need them. Take 30 seconds today to make your voice heard: https://bit.ly/3JS0lVn
Our Fall/Winter 2025 Impact Report is now live! Discover how your support is helping transform the future for everyone living with Crohn’s disease and ulcerative colitis. Read now: https://bit.ly/3XeXIA2
November 7, 2025 at 6:54 PM
Our Fall/Winter 2025 Impact Report is now live! Discover how your support is helping transform the future for everyone living with Crohn’s disease and ulcerative colitis. Read now: https://bit.ly/3XeXIA2
More options for IBD patients! Starjemza™ (ustekinumab-hmny), a biosimilar to Stelara®, is now available through Mark Cuban Cost Plus Drug Company. Approved for adults with moderate to severe Crohn’s and ulcerative colitis. Questions? Contact info@crohnscolitisfoundation.org. https://bit.ly/4hIQUEi
November 6, 2025 at 7:06 PM
More options for IBD patients! Starjemza™ (ustekinumab-hmny), a biosimilar to Stelara®, is now available through Mark Cuban Cost Plus Drug Company. Approved for adults with moderate to severe Crohn’s and ulcerative colitis. Questions? Contact info@crohnscolitisfoundation.org. https://bit.ly/4hIQUEi
Reposted by Crohn's & Colitis Foundation
We’re honored to team up with the @crohnscolitisfdn.bsky.social to spotlight how biosimilars can transform access to essential treatments.
Partnerships like this show what is possible when organizations come together with a shared mission!
Partnerships like this show what is possible when organizations come together with a shared mission!
Available Medications | Mark Cuban Cost Plus Drugs Company
Find your medications online. Browse medications alphabetically. Select your medications. See drug prices. Filter by condition.
costplusdrugs.com
November 6, 2025 at 6:31 PM
We’re honored to team up with the @crohnscolitisfdn.bsky.social to spotlight how biosimilars can transform access to essential treatments.
Partnerships like this show what is possible when organizations come together with a shared mission!
Partnerships like this show what is possible when organizations come together with a shared mission!
Reposted by Crohn's & Colitis Foundation
The Foundation’s APP IBD Education Series is now streaming!
16 expert-led sessions provide essential training in adult/pediatric #IBD —
perfect for NPs, PAs, and all clinicians advancing IBD care.
🎥 Watch on YouTube: https://bit.ly/493m6vV
#IBDPro #MedicalEducation
16 expert-led sessions provide essential training in adult/pediatric #IBD —
perfect for NPs, PAs, and all clinicians advancing IBD care.
🎥 Watch on YouTube: https://bit.ly/493m6vV
#IBDPro #MedicalEducation
October 24, 2025 at 3:35 PM
The Foundation’s APP IBD Education Series is now streaming!
16 expert-led sessions provide essential training in adult/pediatric #IBD —
perfect for NPs, PAs, and all clinicians advancing IBD care.
🎥 Watch on YouTube: https://bit.ly/493m6vV
#IBDPro #MedicalEducation
16 expert-led sessions provide essential training in adult/pediatric #IBD —
perfect for NPs, PAs, and all clinicians advancing IBD care.
🎥 Watch on YouTube: https://bit.ly/493m6vV
#IBDPro #MedicalEducation
Dr. Alan Moss, the Foundation's Chief Scientific Officer, recently spoke with AARP about common causes of digestive symptoms like nausea and diarrhea. He explains how these symptoms can sometimes point to more serious conditions, like Crohn’s disease and ulcerative colitis. https://bit.ly/43Iy4r2
November 4, 2025 at 2:36 PM
Dr. Alan Moss, the Foundation's Chief Scientific Officer, recently spoke with AARP about common causes of digestive symptoms like nausea and diarrhea. He explains how these symptoms can sometimes point to more serious conditions, like Crohn’s disease and ulcerative colitis. https://bit.ly/43Iy4r2
A new oral treatment improved clinical remission and endoscopic outcomes for moderately to severely active ulcerative colitis patients who failed multiple prior therapies, two phase III trials showed. Results, while encouraging, warrant further research, said Alan Moss, MD. Read more: bit.ly/4olysnM
November 3, 2025 at 6:53 PM
A new oral treatment improved clinical remission and endoscopic outcomes for moderately to severely active ulcerative colitis patients who failed multiple prior therapies, two phase III trials showed. Results, while encouraging, warrant further research, said Alan Moss, MD. Read more: bit.ly/4olysnM
Advocacy in action! 60+ Foundation advocates traveled from 23 states to DC, championing IBD policies. Watch our Day on the Hill video—hear their stories and celebrate the Safe Step Act’s introduction in both Senate & House! #IBDDayontheHill youtu.be/T7uZZSSW_fU?si=FqI73jPM6Rw3V1Ql
Advocating for Crohn's & Colitis Patients on Capitol Hill | Support the Safe Step Act & IBD Research
We're on Capitol Hill in Washington, D.C. to raise our voices for the Crohn's and colitis community. Together, patients, caregivers, and advocates are meeting with lawmakers to:
✅ Support critical IBD research and treatment advancements
✅ Advocate for t...
youtu.be
October 31, 2025 at 3:48 PM
Advocacy in action! 60+ Foundation advocates traveled from 23 states to DC, championing IBD policies. Watch our Day on the Hill video—hear their stories and celebrate the Safe Step Act’s introduction in both Senate & House! #IBDDayontheHill youtu.be/T7uZZSSW_fU?si=FqI73jPM6Rw3V1Ql
While Crohn’s is often linked to weight loss, some people experience unintentional weight gain—sometimes due to meds or lifestyle changes. Dr. Alan Moss, our Chief Scientific Officer, was featured in @everydayhealth.bsky.social discussing the factors behind this. Learn more: https://bit.ly/3L80ep3
October 28, 2025 at 6:36 PM
While Crohn’s is often linked to weight loss, some people experience unintentional weight gain—sometimes due to meds or lifestyle changes. Dr. Alan Moss, our Chief Scientific Officer, was featured in @everydayhealth.bsky.social discussing the factors behind this. Learn more: https://bit.ly/3L80ep3
We’re honored to receive the Healio Disruptors Innovators Award in the Patient Voice category! The patient voice drives everything we do—from research to advocacy. Grateful to Healio, the Association of Black Gastroenterologists and Hepatologists, and the IBD community for inspiring this work.
October 27, 2025 at 5:26 PM
We’re honored to receive the Healio Disruptors Innovators Award in the Patient Voice category! The patient voice drives everything we do—from research to advocacy. Grateful to Healio, the Association of Black Gastroenterologists and Hepatologists, and the IBD community for inspiring this work.
New research in Crohn’s & Colitis 360 shows people with IBD using GLP-1 meds—usually for diabetes/obesity—have lower risk of major heart complications. The findings suggest these therapies may offer protective cardiovascular benefits for those with IBD. https://bit.ly/4oBTPkB
October 22, 2025 at 2:15 PM
New research in Crohn’s & Colitis 360 shows people with IBD using GLP-1 meds—usually for diabetes/obesity—have lower risk of major heart complications. The findings suggest these therapies may offer protective cardiovascular benefits for those with IBD. https://bit.ly/4oBTPkB
Could preventing IBD become a reality? In our new Inflammatory Bowel Diseases® Journal special supplement, researchers explore genetics, early-life environmental risks, and biomarkers pointing toward a future of IBD prevention — not just treatment. https://bit.ly/4nWVMbg
October 16, 2025 at 4:07 PM
Could preventing IBD become a reality? In our new Inflammatory Bowel Diseases® Journal special supplement, researchers explore genetics, early-life environmental risks, and biomarkers pointing toward a future of IBD prevention — not just treatment. https://bit.ly/4nWVMbg
We’re celebrating Hispanic Heritage Month by spotlighting valuable resources for Spanish-speaking IBD patients and caregivers! Explore the Foundation’s Spanish-language website—a dedicated site offering trusted info and support in Spanish. Check it out here: https://bit.ly/3XwJgmY
October 7, 2025 at 5:08 PM
We’re celebrating Hispanic Heritage Month by spotlighting valuable resources for Spanish-speaking IBD patients and caregivers! Explore the Foundation’s Spanish-language website—a dedicated site offering trusted info and support in Spanish. Check it out here: https://bit.ly/3XwJgmY
Curious about the Foundation's impact? Check out our new Impact Report to see what we've achieved - and what's next! https://bit.ly/4moWWLX
October 2, 2025 at 3:35 PM
Curious about the Foundation's impact? Check out our new Impact Report to see what we've achieved - and what's next! https://bit.ly/4moWWLX
Camp Oasis campers showed us what #IBDLooksLike. The top three camper designs are in, and only one will become our winner. Voting ends today! https://bit.ly/4gnnGKl
This contest is proudly sponsored by Kate Farms, supporting our mission of improving the lives of people with IBD.
This contest is proudly sponsored by Kate Farms, supporting our mission of improving the lives of people with IBD.
September 30, 2025 at 6:45 PM
Camp Oasis campers showed us what #IBDLooksLike. The top three camper designs are in, and only one will become our winner. Voting ends today! https://bit.ly/4gnnGKl
This contest is proudly sponsored by Kate Farms, supporting our mission of improving the lives of people with IBD.
This contest is proudly sponsored by Kate Farms, supporting our mission of improving the lives of people with IBD.
Several major advances in Crohn's disease have marked 2025. Our Chief Scientific Officer, Dr. Alan Moss, was recently quoted in MedPage Today, providing expert insight on what these developments mean for patients. https://bit.ly/4882kPd
September 29, 2025 at 9:27 PM
Several major advances in Crohn's disease have marked 2025. Our Chief Scientific Officer, Dr. Alan Moss, was recently quoted in MedPage Today, providing expert insight on what these developments mean for patients. https://bit.ly/4882kPd
Our new Strategic Plan Progress Tracker is here — a central hub where you can follow our progress in turning our 2025–2028 goals into action. From advancing research and expanding education to breaking down barriers to care and supporting people affected by IBD. Read more: https://bit.ly/48p9Qpd
September 29, 2025 at 5:05 PM
Our new Strategic Plan Progress Tracker is here — a central hub where you can follow our progress in turning our 2025–2028 goals into action. From advancing research and expanding education to breaking down barriers to care and supporting people affected by IBD. Read more: https://bit.ly/48p9Qpd
Camp Oasis campers designed T‑shirts showing what #IBDlookslike 💜 The top 3 are in—only 1 will be our Awareness Week shirt! Vote by 9/30: bit.ly/4gnnGKl
This contest is proudly sponsored by Kate Farms,
supporting our mission of improving the lives of people with IBD.
This contest is proudly sponsored by Kate Farms,
supporting our mission of improving the lives of people with IBD.
September 25, 2025 at 6:37 PM
Camp Oasis campers designed T‑shirts showing what #IBDlookslike 💜 The top 3 are in—only 1 will be our Awareness Week shirt! Vote by 9/30: bit.ly/4gnnGKl
This contest is proudly sponsored by Kate Farms,
supporting our mission of improving the lives of people with IBD.
This contest is proudly sponsored by Kate Farms,
supporting our mission of improving the lives of people with IBD.